» Articles » PMID: 33245729

Intracellular Hyaluronic Acid-binding Protein 4 (HABP4): a Candidate Tumor Suppressor in Colorectal Cancer

Overview
Journal Oncotarget
Specialty Oncology
Date 2020 Nov 27
PMID 33245729
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Hyaluronic Acid-binding protein 4 (HABP4) is a regulatory protein of 57 kDa that is functionally involved in transcription regulation and RNA metabolism and shows several characteristics common to oncoproteins or tumor suppressors, including altered expression in cancer tissues, nucleus/cytoplasm shuttling, intrinsic lack of protein structure, complex interactomes and post translational modifications. Its gene has been found in a region on chromosome 9q22.3-31, which contains SNP haplotypes occurring in individuals with a high risk for familial colon cancer. To test a possible role of HABP4 in tumorigenesis we generated knockout mice by the CRISPR/Cas9 method and treated the animals with azoxymethane (AOM)/dextran sodium sulfate (DSS) for induction of colon tumors. -/- , compared to wild type mice, had more and larger tumors, and expressed more of the proliferation marker proteins Cyclin-D1, CDK4 and PCNA. Furthermore, the cells of the bottom of the colon crypts in the -/- divided more rapidly. Next, we generated also HABP4/- HCT 116 cells, in cell culture and found again an increased proliferation in clonogenic assays in comparison to wild-type cells. Our study of the protein expression levels of HABP4 in human colon cancer samples, through immunohistochemistry assays, showed, that 30% of the tumors analyzed had low expression of HABP4. Our data suggest that HABP4 is involved in proliferation regulation of colon cells and and that it is a promising new candidate for a tumor suppressor protein that can be explored both in the diagnosis and possibly therapy of colon cancer.

Citing Articles

circ-1584 selectively promotes the antitumor activity of the oncolytic virus M1 on pancreatic cancer.

Hao T, Li Y, Ren Q, Zeng Y, Gao L, Zhu W Mol Ther Oncol. 2025; 33(1):200919.

PMID: 39866243 PMC: 11760297. DOI: 10.1016/j.omton.2024.200919.


Hyaluronic Acid Interacting Molecules Mediated Crosstalk between Cancer Cells and Microenvironment from Primary Tumour to Distant Metastasis.

Xu Y, Benedikt J, Ye L Cancers (Basel). 2024; 16(10).

PMID: 38791985 PMC: 11119954. DOI: 10.3390/cancers16101907.


Obesity-Linked PPARγ Ser273 Phosphorylation Promotes Beneficial Effects on the Liver, despite Reduced Insulin Sensitivity in Mice.

Terra M, Garcia-Arevalo M, Avelino T, Degaki K, de Carvalho M, Torres F Biomolecules. 2023; 13(4).

PMID: 37189379 PMC: 10135908. DOI: 10.3390/biom13040632.


Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer.

Meng H, Nan M, Li Y, Ding Y, Yin Y, Zhang M Front Endocrinol (Lausanne). 2023; 14:1148412.

PMID: 37020597 PMC: 10067930. DOI: 10.3389/fendo.2023.1148412.

References
1.
Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

2.
Heaton J, Dlakic W, Dlakic M, Gelehrter T . Identification and cDNA cloning of a novel RNA-binding protein that interacts with the cyclic nucleotide-responsive sequence in the Type-1 plasminogen activator inhibitor mRNA. J Biol Chem. 2000; 276(5):3341-7. DOI: 10.1074/jbc.M006538200. View

3.
Guo M, Zhang C, Wang Y, Feng L, Wang Z, Niu W . Progesterone Receptor Membrane Component 1 Mediates Progesterone-Induced Suppression of Oocyte Meiotic Prophase I and Primordial Folliculogenesis. Sci Rep. 2016; 6:36869. PMC: 5111101. DOI: 10.1038/srep36869. View

4.
Gray-McGuire C, Guda K, Adrianto I, Lin C, Natale L, Potter J . Confirmation of linkage to and localization of familial colon cancer risk haplotype on chromosome 9q22. Cancer Res. 2010; 70(13):5409-18. PMC: 2896448. DOI: 10.1158/0008-5472.CAN-10-0188. View

5.
Hlavaty J, Ertl R, Miller I, Gabriel C . Expression of Progesterone Receptor Membrane Component 1 (PGRMC1), Progestin and AdipoQ Receptor 7 (PAQPR7), and Plasminogen Activator Inhibitor 1 RNA-Binding Protein (PAIRBP1) in Glioma Spheroids In Vitro. Biomed Res Int. 2016; 2016:8065830. PMC: 4908248. DOI: 10.1155/2016/8065830. View